Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells.
miRNAs may play effective roles in breast cancer so modulating their expression levels could have therapeutic benefits. Recent studies have found the combination of miRNA-based therapeutics with conventional drugs as promising. This study aimed to find drug-responsive miRNAs, and explore their antic...
Main Authors: | Senem Noyan, Hakan Gurdal, Bala Gur Dedeoglu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0215894 |
Similar Items
-
Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells
by: Saber Yari Bostanabad, et al.
Published: (2021-01-01) -
Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines.
by: Emine Ezel Cilek, et al.
Published: (2017-01-01) -
MiR-129-5p Sensitizes the Response of Her-2 Positive Breast Cancer to Trastuzumab by Reducing Rps6
by: Xiangdong Lu, et al.
Published: (2017-12-01) -
miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines
by: Lihi Ninio-Many, et al.
Published: (2020-02-01) -
Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells.
by: Takehiro Ichikawa, et al.
Published: (2012-01-01)